A prospective study by Colombo et al. (2002) found the F508del mutation in approximately 51–55% of CF patients with cystic fibrosis liver disease (CFLD), suggesting a correlation between specific CFTR genotypes and variable liver phenotypes [172]. This evidence concerns the gene CFTR and cystic fibrosis-related liver disease.